We are committed to improving the lives of people suffering from traumatic injuries and degenerative disease. We aim to do this in partnership; by listening to patients, supporters and advocacy communities and hearing your stories. It is your words and your resilience that motivate us to advance the understanding of rare disease and work to deliver new treatments to as many patients as possible.
Allegro is currently concluding pre-clinical trials on its lead asset in osteoarthritis.
Register for the Osteoarthritis Trial
The clinical trial for osteoarthritis in Belgium is expected to start in 2025. If you would like to be informed, please get in touch.